Trending Now
Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) Announces Its Q3 2020 Financial Results And...
Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) has announced its Q3 2020 financial results and provided business highlights. The company recognized revenue of $48.9 million in Q3...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Wall Street is now All-In on the Metaverse, and these Stocks...
The titans of Wall Street are nearly unanimous now: the Metaverse is going to be an economic explosion with huge implications for...
MAKE IT MODERN
LATEST REVIEWS
Evofem Biosciences Inc. (NASDAQ:EVFM) Announces that Phase 3 EVO100 Trial Is...
Evofem Biosciences Inc. (NASDAQ:EVFM) has announced that its third phase pivotal EVO100 trial, ‘EVOGUARD’ for chlamydia and gonorrhea prevention, is firmly on...
MAKE IT MODERN
PERFORMANCE TRAINING
BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) Demonstrates Improvement In Hemoglobin Using BCX9930 In PNH Patients
BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) showed improvement in hemoglobin and lowered transfusions using BCX9930, its oral D-factor, in PNH (paroxysmal nocturnal hemoglobinuria) patients in an...
Compugen Ltd. (NASDAQ: CGEN) Announces New USPTO Covering Method Of Use Of COM701
Compugen Ltd. (NASDAQ: CGEN) has announced that the USPTO has granted it a new patent covering a method of use for COM701. COM701 is...
Mustang Bio Inc (NASDAQ: MBIO) Receives Orphan Drug Designation From US FDA For MB-106...
Mustang Bio Inc (NASDAQ: MBIO) has received an Orphan Drug Designation from the US FDA for its CD20-targeted, autologous CAR T cell therapy, MB-106,...
Baudax Bio Inc (NASDAQ: BXRX) Issues an Update on Its Novelty Drug ANJESCO
Baudax Bio Inc (NASDAQ: BXRX) recently announced its intention to begin a clinical study investigating whether the administration of pharmacokinetics injections in minors between...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Enters Co-Promotion Partnership Deal For Probuphine Implant With Indegene
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced that it has signed a co-promotion partnership agreement with Indegene Inc. The partnership is meant to establish multichannel...
MAKE IT MODERN
